Gaudium IVF and Women Health Limited Share Price & Stock Analysis

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; infertility surgeries; egg freezing; surrogacy; and laparoscopic and hysteroscopic surgeries for the diagnosis and treatment of infertility-related conditions, as well as offers genetic testing options, including preimplantation genetic testing (PGT); and IVF consultancy services. In addition, the company operates hospital, in-house pharmacy; and 7 hubs (IVF centers) and 28 spokes. The company was founded in 2009 and is based in headquartered in New Delhi, India.

Key Metrics

Current Price₹93.83
Market Cap₹738 Cr
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Services > Medical Diagnostic Centres
P/E Ratio25
Return on Equity16.08%
52-Week Range₹69.18 – ₹163.18
Beta (1Y)0.74

Latest Quarterly Results — Q1 FY27

Revenue₹19 Cr
Net Profit₹2 Cr
EPS (Basic)₹0.25
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Business Segments

1. Healthcare Facilities & Services-100%

Peer Companies

Frequently Asked Questions

What is the current share price of Gaudium IVF and Women Health Limited?

Gaudium IVF and Women Health Limited is trading at ₹93.83, with a market capitalisation of ₹738 Cr.

Which sector does Gaudium IVF and Women Health Limited belong to?

Gaudium IVF and Women Health Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).

What are the key financial ratios of Gaudium IVF and Women Health Limited?

Gaudium IVF and Women Health Limited has a P/E of 25 and a return on equity of 16.08%.

What were Gaudium IVF and Women Health Limited's latest quarterly results?

In Q1 FY27, Gaudium IVF and Women Health Limited reported revenue of ₹19 Cr and net profit of ₹2 Cr, with basic EPS of ₹0.25 (consolidated, parsed from the company's exchange filing).